Warner Chilcott

:

Procter & Gamble (Prescription-drug business)

Dealogic Deal #  :

609261

Data as of :

8/24/2009

Target

Acquiror

Dates & Values

Procter & Gamble (Prescription-drug business)

Warner Chilcott

Target:

100

% stake

Buying:

100

% stake

Rumored

5th Feb 2009

Deal Value $m

3,100.0

Unlisted

0

0

m shares outstanding

Private (Not listed)

Announced

24th Aug 2009

Value ex Debt $m

3,100.0

United States

United Kingdom

Healthcare

Healthcare

Expected

4Q 2009

Consideration

Goldman Sachs | Advisor

Citigroup Global Markets | Advisor

Completed

-

Covington & Burling | Attorney

JP Morgan | Advisor

Barclays Capital | Advisor

Withdrawn

-

Morgan Stanley | Advisor

Credit Suisse | Advisor

Termination Fee, Target $m

tbd

Bank of america Merrill Lynch | Advisor

Davis Polk & Wardwell | Attorney

Timeline Events

Termination Fee, Acquiror $m

tbd

Financials

-

Balance Sheet

Debt/Equity:

-

Premiums & Multiples

Initial Offer

-

Current Offer

-

Income Statement

Cash Flows

Operations $m

0

Profitability

Profit Margin

-

Return on Equity

-

League Table Impact

Sector Trend

2009 YTD Announced Global M&A by Deal Value, $bn

Monthly Announced Global M&A, $bn:

Healthcare

1

Goldman Sachs

406.6

2

Morgan Stanley

398.3

3

JPMorgan

362.7

4

Citi

306.6

5

BOA Merrill Lynch

253.5

6

Lazard

237.5

7

Deutsche Bank

226.8

8

UBS

186.1

9

Credit Suisse

168.5

10

Barclays Capital

133.0

© 2009 Dealogic.  All rights reserved.